Skip to main content

Table 1 Main characteristics of the included studies

From: Diagnostic effect of shear wave elastography imaging for differentiation of malignant liver lesions: a meta-analysis

Author,year

Country

Elastography modality

Instrument

No.of patients

No.of liver lesions (Malignant)

Invalid measures(%)

Lesion types

Reference standard

Cut-off value (SWE/SWV ratio)

Cho et al., 2010 [19]

Korea

pSWE

Siemens, ACUSON S2000

51

60(43)

21.7%

HCC,CCC,LM,haemangioma

histopathology, CT/MRI

2 m/s

Davies et al., 2011 [21]

Holland

pSWE

Siemens, ACUSON S2000

37

45(10)

NR

haemangioma,LM

biopsy,CT/MRI

2.5 m/s (1.6)

Shuang-Ming et al., 2011 [20]

China

pSWE

Siemens, ACUSON S2000

116

128(68)

22.7%

HCC, CCC,LM, haemangioma,FNH,RN,FFS,FFC,abscess,adenoma,SNN

histopathology, CT/MRI

2.22 m/s

Yu et al., 2011 [23]

Canada

pSWE

Siemens, ACUSON S2000

89

105(41)

6.1%

HCC,LM,haemangioma,FNH,FFS,FFD,adenoma

biopsy, CT/MRI

1.9 m/s

Kapoor et al., 2011 [22]

India

pSWE

Siemens, ACUSON S2000

42

42(27)

12.5%

HCC,LM,haemangiomas,lymphomas,FNH,sarcoid,abscesses,FFS

biopsy

2.5 m/s

Kim et al., 2013 [26]

Korea

pSWE

Siemens, ACUSON S2000

74

101(73)

NR

HCC,CCC,LM, hemangioma

pathology, CT/MRI

2.73 m/s

Park et al., 2013 [27]

Korea

pSWE

Siemens, ACUSON S2000

47

47(39)

20%

HCC,CCC,LM,haemangioma,FNH

histopathology, CT/MRI

1.82 m/s

Zhang et al., 2014 [28]

China

pSWE

Siemens, ACUSON S2000

156

170(112)

9.7%

HCC,CCC,LM,hemangioma,FNH,RN

histopathology, CT/MRI,DSA

2.16 m/s

Guo et al., 2015 [25]

China

pSWE

Siemens, ACUSON S2000

134

134(55)

11.0%

HCC,CCC,LM,hemangioma,focal fatty degeneration,FFS,FNH, abscess

pathology, CT/MRI

2.13 m/s (1.37)

Lu et al., 2015 [24]

China

pSWE(Elast PQ)

Philips iu22

259

259(201)

1.2%

HCC,ICC,LM,hemangioma, FNH, CN

histopathology

13Kpa (1.3)

Wu et al., 2016 [29]

China

pSWE

Siemens, ACUSON S2000

46

55(27)

NR

HCC,LM,hemangioma,FFS,RN

pathology, CEUS, CT/MRI

2.22 m/s

Dong et al., 2017 [30]

China

pSWE(ElastPQ)

Philips EPIQ7

154

154(129)

NR

HCC,ICC,CHC,sarcoma,LM,AML,FNH,hemangioma,IPT

histopathology

2.06 m/s (1.67)

Wen-Shuo et al., 2016 [31]

China

2D-SWE(SuperSonic Imagine)

Aixplorer

221

229(164)

6.6%

HCC,ICC,CHC,LM,sarcomaneuroendocrine cancer,Unclassified cancer,FNH,hemangioma,angioleiomyolipoma,cavernous vascular tumor,abscess,Inflammatory pseudo-tumor,inflammation,solitary fibroma

histopathology,CEUS

Emax39.60Kpa/

Emean24.43 Kpa

Gerber et al., 2017 [32]

Germany

2D-SWE(SuperSonic Imagine)

Aixplorer

106

106(64)

24.3%

haemangioma,FNH, adenoma,FFS, RN,cholangiofibroma, HCC,CCC, LM

histopathology,CEUS, CT/MRI

Emean20.7 Kpa

Grgurevic et al., 2018 [33]

Switzerland

2D-SWE(SuperSonic Imagine)

Aixplorer

196

259(168)

26.3%

HCC,CCC,LM,haemangioma, FNH

biopsy, CT/MRI

Emean22.3 Kpa

  1. No number, HCC hepatocellular carcinoma, ICC intrahepatic cholangiocellular carcinoma, CCC cholangiocarcinoma, CHC Combined hepatocellular carcinoma and intrahepatic cholangiocarcinoma, LMN liver metastasis, FNH focal nodular hyperplasia, FFS focal fatty sparing/ nodule of focal fatty sparing, FFD focal fat deposits, FFC focal fatty change, SNN solitary necrotic nodule, RN regenerative node, CN cirrhotic nodule, AML hepatic angiomyolipoma, IPT inflammatory pseudotumor, CT computer tomography, MRI magnetic resonance imaging, CEUS contrast enhanced ultrasound, MRI; DSA digital subtraction angiography, NR not reported